Biodatup promotes clinical trials using an innovative technology to
provide optimal results that match the needs of this demanding sector.
Created to revolutionize the management of clinical trials, this unique
platform combines the latest advances of engineering in medical information management, with the most innovative techniques of data analysis in health, such as modelling and big data among others.
ADVANTAGES
CONCEPT
Vision
Biodatup was borned with the aim of being a strategic partner involved in a clinical trial.
With the incorporation of Biodatup management systems data coming, from clinical trial will be optimized,
thus ensuring a higher degree of success.
Values
Biodatup was borned with the aim of being a strategic partner involved in a clinical trial.
With the incorporation of Biodatup management systems data coming, from clinical trial will be optimized,
thus ensuring a higher degree of success.
OUR TEAM
PhD experts in pharmacometrics, telecom engineers, biochemistry & cellular biology, chemistry, mathematics and
pharmacognosy work together with pharmacy graduates, physics, chemistry, engineers and pedagogy graduates to develop the whole potential
of our products and services.
The combination of these expertise and our unrivaled passion for our work, produces
a really excellent result for our coustomers.
Proyectos y subvenciones
TXEKINTEK / EKINTZAILE
PROGRAMA PROMOVIDO POR
2018- ENPRESAK SORTU ETA GARATZEKO PROZESUAN LAGUNTZEKO PROGRAMA
PROGRAMA PARA EL ACOMPAÑAMIENTO EN EL PROCESO DE CREACIÓN Y DESARROLLO EMPRESARIAL- 2018
OBJETO:
Apoyo mediante el acompañamiento y la financiación para nuevos proyectos empresariales de carácter innovador industrial o de servicios conexos, tutelados por un BIC (Business Innovation Center), para las fases de maduración de la idea y de puesta en marcha de la empresa.
Ayuda de acompañamiento, a la persona o equipo promotor, en el proceso de maduración de la idea y elaboración del Plan de Empresa, hasta la puesta en marcha. Esta ayuda tendrá la consideración de subvención a fondo perdido no reintegrable.
PRESUPUESTO: 35.000 €
Objective:
Clinical Trials (CT) are designed to prove if a drug, device or therapy is safe and effective in the human body, so they are already tested in individuals. The CT investigators and sponsors spend great amount of resources on data management and project and data quality control. In 2017 more than 120,000 CT have been registered, of which near 31,000 are carried out in the EU. Usually the average duration of CT from start to marketing is 7.5 years, however, more than 80% of CT are delayed from 1 to 6-month costing to the companies upwards of 30,000 € per day per trial. In most of the cases, this delay is due to inefficient management systems. With CT conducted in over 140 countries, the complexity and rate of change in trials is increasing. Considering this huge business opportunity, we have been working in a customizable software system to manage and simplify CT development. iMOTED platform will ensure high quality data, collected from multiple sources by using real time analysis of data, a simple and intuitive interface, generation of real time alarms employing estimations, predictions & simulations. In this way, we expect to reduce the economic losses that pharma industry has when launching a new drug, for whom only 2 out of 10 marketed drugs return revenues that exceed R&D costs. iMOTED belongs to the e-clinic market, which is forecasted to reach €7.6 Bn by 2022 growing at a CARG of 12.4% over the period 2017-2022. We will initially target Europe as our domestic market, to start selling the IMOTED licenses. We expect to have our breakeven point two years after the beginning of the project, a cumulative turnover of €13 M by 2022, that will give us a ROI of 560% in 2024. Hence, at this stage of development we believe that we need to perform a through feasibility study to assess for the challenges and tasks that we still must accomplish to launch iMOTED for what we are asking for EC support.
